SAB Biotherapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- SAB Biotherapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- SABS
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001833214
Board of directors
-
Andrew Moin · DirectorSince 2023
-
Christine E. Hamilton · DirectorSince 2023
-
David Charles Link · DirectorSince 2024
-
Eddie Joe Sullivan · Director · PRESIDENTSince 2023
-
Erick Lucera · DirectorSince 2023
-
Helen K. Ellias · DirectorSince 2023
-
Jay S. Skyler · DirectorSince 2024
-
Jeffrey G. Spragens · DirectorSince 2023
-
John Petry · DirectorSince 2023
-
Samuel J. Reich · Director · CEO & EXECUTIVE CHAIRMANSince 2023
-
Scott Giberson · DirectorSince 2024
-
William James Polvino · DirectorSince 2024
Chief executives
Eddie Joe Sullivan
· Chief Executive Officer
Dates unknown
Samuel J. Reich
· CEO & EXECUTIVE CHAIRMAN
Dates unknown
Board connections
3 of this board's directors also sit on 4 other boards.
- via Erick Lucera
- via Erick Lucera
- via Jay S. Skyler
- via Christine E. Hamilton
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 2024 | Alexandra Kropotova Officer (CHIEF MEDICAL OFFICER) | Shares withheld for tax | −9,072 | — | — |
| Dec 7, 2023 | Eddie Joe Sullivan Director, Officer (Chief Executive Officer) | Open-market purchase | +1,740 | $0.88 | $1,531 |
| Nov 30, 2023 | King Michael Officer (CHIEF FINANCIAL OFFICER) | Open-market purchase | +5,000 | $0.90 | $4,500 |
| Nov 29, 2023 | Samuel J. Reich Director, Officer (Executive Chairman) | Open-market purchase | +11,000 | $0.89 | $9,790 |
| Nov 24, 2023 | Sessa Capital IM GP, LLC Director | Option exercise | +4,584,571 | — | — |
| Nov 24, 2023 | Andrew Moin Director | Option exercise | +4,584,571 | — | — |
| Nov 24, 2023 | Helen K. Ellias Director | Option exercise | +2,857,142 | — | — |
| Mar 14, 2023 | Kropotova Alexandra Officer (Chief Medical Officer) | Grant or award | +275,000 | — | — |
| Jun 7, 2022 | Christine E. Hamilton Director, 10% owner | Gift | −2,000,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.